乳腺癌区域淋巴结照射的放疗野设计与淋巴水肿风险
研究纳入1999至2013年526例接受区域淋巴结照射的II-IV期乳腺癌术后患者,按腋窝上I、II站是否纳入分为三组。中位随访5.5年,492例符合标准者2年淋巴水肿累积发生率为23.5%、5年为31.8%;单因素分析显示未纳入腋窝上I、II站组5年淋巴水肿率7.7%,低于纳入组(37.1%和36.7%,P<.0001),多因素分析显示纳入腋窝上I、II站仍与淋巴水肿风险增加显著相关。
要点
- 未纳入腋窝上I、II站组5年淋巴水肿率为7.7%,纳入组分别为37.1%和36.7%(P<.0001)。
- 492例符合标准者2年淋巴水肿累积发生率为23.5%,5年为31.8%。
- 多因素分析显示纳入腋窝上I、II站仍与淋巴水肿风险增加显著相关。
核心结论
- 放疗野设计的变化显著影响区域淋巴结照射后淋巴水肿的发生。
- 腋窝上I、II站似乎是腋窝清扫后淋巴水肿风险的重要区域。
研究设计与样本
- 研究纳入1999至2013年接受乳腺手术后区域淋巴结照射的II-IV期乳腺癌女性,手术包括前哨淋巴结活检或腋窝清扫。
- 放疗前及每次随访时测量臂围以评估淋巴水肿,淋巴结放疗野采用三分法定义。
- 第1组不包含腋窝上I、II站,淋巴结野外侧界覆盖肱骨头不足三分之一。
- 第2组包含腋窝上I、II站,淋巴结野外侧界覆盖肱骨头超过三分之一,采用前斜野照射。
- 第3组包含腋窝上I、II站同第2组,但采用平行对穿野对腋窝后肌肉组织给予显著剂量。
主要发现
- 1999至2013年共526例女性接受区域淋巴结照射,放疗后中位随访5.5年。
- 492例符合纳入标准者淋巴水肿累积发生率2年为23.5%、5年为31.8%。
- 单因素分析中第1组5年淋巴水肿率7.7%,低于第2组37.1%和第3组36.7%(P<.0001)。
- 多因素分析中纳入腋窝上I、II站(第2组和第3组)仍与淋巴水肿风险增加显著相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The occurrence of upper extremity lymphedema after regional nodal irradiation (RNI) for breast cancer treatment varies significantly based on patient and treatment factors. The relationship between the radiation therapy (RT) field design and lymphedema risk is not well-characterized. The present study sought to correlate the variations in RT field design with lymphedema outcomes. METHODS AND MATERIALS: Women with stage II-IV breast cancer receiving RNI after breast surgery that included sentinel lymph node biopsy or axillary dissection were identified. Their arm circumference was measured before RT and at each follow-up visit to assess for lymphedema. Nodal RT fields were defined using a trifurcated system. Group 1 excluded the upper level I and II axilla, defined by the lateral border of the nodal field encompassing less than one-third of the humeral head. Group 2 included the upper level I and II axilla, defined by the lateral border of the nodal field encompassing more than one-third of the humoral head treated with an anterior oblique beam. Group 3 included the upper level I and II axilla the same as for group 2 but with parallel-opposed beams delivering a significant dose to the musculature posterior to the axilla. RESULTS: From 1999 to 2013, 526 women received RNI. The median post-RT follow-up was 5.5 years. For the 492 women meeting the inclusion criteria, the cumulative incidence of lymphedema was 23.5% at 2 years and 31.8% at 5 years. On univariate analysis, the patients in group 1 had a lower 5-year lymphedema rate (7.7%) than those in group 2 (37.1%) and group 3 (36.7%; P < .0001). On multivariate analysis, inclusion of the upper level I and II axilla (groups 2 and 3) remained significantly associated with increased lymphedema risk. CONCLUSIONS: Variations in the RT field design significantly affect the development of lymphedema after RNI. In particular, the upper level I and II axilla appear to be important regions for lymphedema risk after axillary dissection.
引用
- Gross JP, Sachdev S, Helenowski IB, et al. Radiation Therapy Field Design and Lymphedema Risk After Regional Nodal Irradiation for Breast Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 30102206. doi:10.1016/j.ijrobp.2018.03.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。